Investing.com - Financial Markets Worldwide

Biocept Inc (BIOCQ)

OTC Markets
Currency in USD
0.050
0.000(0.00%)
Delayed Data·
BIOCQ Scorecard
Full Analysis
Stock generally trades with high price volatility
BIOCQ is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
0.0500.050
52 wk Range
0.0010.060
Key Statistics
Edit
Prev. Close
-
Open
0.05
Day's Range
0.05-0.05
52 wk Range
0.001-0.06
Volume
-
Average Volume (3m)
10.72K
1-Year Change
900%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BIOCQ Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 7
Suffers from weak gross profit margins
Unlock InvestingPro

Biocept Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Biocept Inc Company Profile

Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary clinical diagnostic laboratory assays designed to identify rare tumor cells and cell-free tumor DNA from blood and cerebrospinal fluid, or CSF in the United States. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resistance mechanisms. The company offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer (NSCLC), gastric cancer, colorectal cancer, prostate cancer, pancreaticobiliary cancer, and ovarian cancer. It also provides cerebrospinal fluid tumor cell and ctDNA and ctRNA testing services to medical oncologists, neuro-oncologists, surgical oncologists, radiation oncologists, urologists, pulmonologists, pathologists, and other physicians; and clinical trial and research services to pharmaceutical companies, biopharmaceutical companies and clinical research organizations. The company has a collaboration with CLEARED4 to develop a system for tracking and managing COVID-19 testing requirements and test results for its customers; and with Protean BioDiagnostics, Inc. to research the ability of its Target Selector molecular assay to determine EGFR status in NSCLC patients. Biocept, Inc. was incorporated in 1997 and is headquartered in San Diego, California. On October 13, 2023, Biocept, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.

Industry
Healthcare Equipment & Supplies
Sector
Healthcare
Employees
50
Market
United States

Compare BIOCQ to Peers and Sector

Metrics to compare
BIOCQ
Peers
Sector
Relationship
P/E Ratio
0.0x−3.6x−0.5x
PEG Ratio
0.00−0.110.00
Price/Book
0.0x2.8x2.6x
Price / LTM Sales
0.0x10.0x3.3x
Upside (Analyst Target)
0.0%252.6%43.5%
Fair Value Upside
Unlock0.2%6.9%Unlock

Earnings

Latest Release
Aug 14, 2023
EPS / Forecast
-3.50 / --
Revenue / Forecast
589.00K / 1.65M
EPS Revisions
a
a
Unlock
Last 90 days

BIOCQ Income Statement

FAQ

What Stock Exchange Does Biocept Trade On?

Biocept is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Biocept?

The stock symbol for Biocept is "BIOCQ."

What Is the Biocept Market Cap?

As of today, Biocept market cap is 131.30K.

What Is Biocept's Earnings Per Share (TTM)?

The Biocept EPS (TTM) is -44.33.

From a Technical Analysis Perspective, Is BIOCQ a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Biocept Stock Split?

Biocept has split 4 times.

How Many Employees Does Biocept Have?

Biocept has 50 employees.

What is the current trading status of Biocept (BIOCQ)?

As of 07 Aug 2025, Biocept (BIOCQ) is trading at a price of 0.05, with a previous close of 0.00. The stock has fluctuated within a day range of 0.05 to 0.05, while its 52-week range spans from 0.00 to 0.06.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.